Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity-a cross-sectional clinical study
- PMID: 38495904
- PMCID: PMC10940440
- DOI: 10.3389/fpsyt.2024.1303778
Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity-a cross-sectional clinical study
Abstract
Introduction: Recent research highlights the significance of insomnia and sleepiness, shifting from obstructive sleep apnea (OSA) severity and sleep structure, in defining OSA phenotypes.
Objectives: This study aimed to characterize insomnia and sleepiness associated with OSA phenotypes and assess their involvement in depression symptoms (DS) in OSA.
Materials and methods: This cross-sectional, clinical study included 181 participants who underwent polysomnography (PSG) and filled out questionnaires, including the Epworth Sleepiness Scale (ESS), Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Index (BDI). They were categorized into phenotypes: insomnia-sleepiness (I + S; ESS ≥ 11; ISI ≥ 15; n = 20), sleepiness (S; ESS ≥ 11; ISI < 15; n = 22), insomnia (I; ESS < 11; ISI ≥ 15), and asymptomatic (A; ESS < 11; ISI<15; n=55).
Results: A linear regression model for the BDI score (R2 = 0.357, p < 0.001) included ISI score and subjective-to-objective sleep latency ratio. The ISI score was a predictive factor for mild and moderate DS [OR = 1.23 (95% CI: 1.09-1.38), p < 0.001 and OR = 1.39 (95% CI: 1.13-1.72), p = 0.002]. The I and I + S phenotypes are characterized by higher BDI scores (p < 0.001 and p = 0.02), longer subjective sleep latency (p = 0.008 and p = 0.04), and shorter subjective total sleep time (TST; p = 0.049 and p = 0.006) compared to A. Furthermore, the I and I + S groups had shorter subjective TST than S (p = 0.03 and p = 0.047). The I and I + S had higher BDI scores than A (p < 0.001 and p = 0.02, respectively) and S (p < 0.001 and p = 0.02, respectively). The I phenotype was associated with the risk of mild and moderate DS (OR = 5.61 (95% CI: 1.91-16.53), p < 0.001 and OR = 9.55 (95% CI: 1.81-50.48), p = 0.008 respectively). Moreover, the I + S phenotype presented an even greater risk for mild DS (OR = 10.29 (95% CI: 2.95-35.85), p < 0.001).
Conclusion: Using clinical features for OSA phenotyping holds promise for finding OSA individuals with increased risk for DS occurrence.
Keywords: OSA; depression; excessive daytime sleepiness; insomnia; phenotyping.
Copyright © 2024 Gabryelska, Turkiewicz, Białasiewicz, Grzybowski, Strzelecki and Sochal.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Insomnia features and patient-reported daytime sleepiness in patients with obstructive sleep apnea.Sleep Med. 2025 May;129:292-296. doi: 10.1016/j.sleep.2025.02.035. Epub 2025 Feb 26. Sleep Med. 2025. PMID: 40068581
-
Subjective nocturnal symptoms have different associations with depressive symptoms and anxiety than with daytime sleepiness in patients with obstructive sleep apnea.Sleep Med. 2020 May;69:58-64. doi: 10.1016/j.sleep.2019.12.019. Epub 2020 Jan 11. Sleep Med. 2020. PMID: 32045855
-
The Epworth Sleepiness Scale in epilepsy: Internal consistency and disease-related associations.Epilepsy Behav. 2021 Aug;121(Pt A):108099. doi: 10.1016/j.yebeh.2021.108099. Epub 2021 Jun 5. Epilepsy Behav. 2021. PMID: 34102473
-
Depressive symptoms are associated with poor sleep quality rather than apnea-hypopnea index or hypoxia during sleep in patients with obstructive sleep apnea.Sleep Breath. 2017 Dec;21(4):997-1003. doi: 10.1007/s11325-017-1550-1. Epub 2017 Aug 19. Sleep Breath. 2017. PMID: 28825197
-
Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials.Front Neurol. 2022 Jun 27;13:911996. doi: 10.3389/fneur.2022.911996. eCollection 2022. Front Neurol. 2022. PMID: 35832171 Free PMC article.
Cited by
-
The Influence of Serotonergic Signaling on Quality of Life, Depression, Insomnia, and Hypoxia in Obstructive Sleep Apnea Patients: Cross-Sectional Study.J Clin Med. 2025 Jan 12;14(2):445. doi: 10.3390/jcm14020445. J Clin Med. 2025. PMID: 39860451 Free PMC article.
References
LinkOut - more resources
Full Text Sources